https://im.kommersant.ru/Issues.photo/NEWS/2020/06/03/KMO_141501_05532_1_t219_181524.jpg

Pandemic COVID-19 led to changes in the structure of sales of pharmacy chains. The decline in revenue due to the isolation forced consumers to purchase the cheapest drugs, with the result that the share of drugs in the price segment up to 50 RUB increased in March by 4 percentage points (PP) in April and by another 1 percentage point In March and April 2020 in sales of pharmacy chains has increased the share of low-cost medicines. In March, the share of drugs worth up to 50 RUB. in total volume of sales of furmanniy increased compared with February by 4 percentage points to 34%, and in April in comparison with March and by another 1 p. p. Medicine at a price of 150 rubles was held in March for 24.4% of the total sales of pharmacy chains against 26% in the previous month, but in April, their share increased to 26.2%. These data are presented in the presentation of DSM Group, presented June 3 during an online-conference “Pharmacy market in April: the impact of coronaries”.General Director DSM Group Sergey shuljak connects the trend with the lack of income among consumers, left without work because of the mandatory regime of self-isolation. The transition of the population only on the cheap and necessary drugs confirms and the CEO of the Voronezh network “Farmy” Roman Kubarev.Experts have attributed this to the leaching of categories from the range by the networks, and the latter nodded for inflation and the transition cheap drugs in a higher price segment.In General, after sales growth of pharmacy chains in March by 46.4% year-on-year and by 26.3% in February followed by a sharp decline. According to DSM Group, in April the volume of sales of networks decreased by 2.5% year-on-year and by 29% in March. Analysts noted that sales fell in the regions where it was introduced compulsory admissions. Apart from the fact that the consumers used the campaign to the pharmacy as a reason to leave home due to isolation and reduced physical activity among the population aggravated a chronic disease that required additional treatment, said Sergei Shulyak. In may, the negative dynamics of the sales of preserved. So, according to preliminary results, they declined relative to the previous month by 13% in packages and 6% in money.Maria Cotovelea mandatory labeling of medicines will be launched on 1 July 2020, moving the deadline will not be announced Minister of health Michael Murashko. Thus, concerns about the impact of the pandemic on the timing of the operation of this mechanism is not justified. This means that in a month the turnover of medicines applied digital codes will be denied. Previously received in the sale of medicines without labels will not be confiscated.Read more